1. Home
  2. BUUU vs NERV Comparison

BUUU vs NERV Comparison

Compare BUUU & NERV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

BUUU

BUUU Group Limited Class A Ordinary Share

HOLD

Current Price

$16.39

Market Cap

264.6M

ML Signal

HOLD

Logo Minerva Neurosciences Inc

NERV

Minerva Neurosciences Inc

HOLD

Current Price

$4.78

Market Cap

301.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BUUU
NERV
Founded
2017
2007
Country
Hong Kong
United States
Employees
16
N/A
Industry
Services-Misc. Amusement & Recreation
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
264.6M
301.6M
IPO Year
N/A
2014

Fundamental Metrics

Financial Performance
Metric
BUUU
NERV
Price
$16.39
$4.78
Analyst Decision
Buy
Analyst Count
0
2
Target Price
N/A
$10.50
AVG Volume (30 Days)
15.7K
127.5K
Earning Date
05-18-2026
05-01-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$41,175,600.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
$347.19
N/A
Revenue Growth
N/A
N/A
52 Week Low
$3.97
$1.57
52 Week High
$26.00
$12.46

Technical Indicators

Market Signals
Indicator
BUUU
NERV
Relative Strength Index (RSI) 43.94 37.30
Support Level $13.53 $3.69
Resistance Level $19.09 $5.61
Average True Range (ATR) 2.44 0.45
MACD -0.27 -0.02
Stochastic Oscillator 7.35 36.88

Price Performance

Historical Comparison
BUUU
NERV

About BUUU BUUU Group Limited Class A Ordinary Share

BUUU Group Ltd provides comprehensive meetings, incentives, conferences, and exhibitions (MICE) solutions focused on event management and stage production. Its event management team offers creative planning, project management, and on-site supervision for a wide range of cultural, artistic, recreational, and corporate events, working closely with clients and partners. The stage production team creates immersive event experiences by managing lighting, audio-visual systems, stage performance elements, and venue decorations, overseeing the entire production process. Event management generates the majority of revenue.

About NERV Minerva Neurosciences Inc

Minerva Neurosciences Inc a clinical-stage biopharmaceutical company focused on the development and commercialization of certain proprietary product candidates to treat patients suffering from central nervous system (CNS) diseases. Its product candidate, Roluperidone, is in development for the treatment of negative symptoms in patients diagnosed with schizophrenia. Its Clinical-Stage Programs include Roluperidone and Seltorexant. The company's operations are organized into one operating and reportable segment focused on the development and commercialization of proprietary product candidates to treat patients suffering from CNS diseases.

Share on Social Networks: